Obstetric outcome in antiphospholipid syndrome

Lupus

Volumn 6, Issue 6, 1997, Pages 509-513

  Granger, K A ^a   Farquharson, R G ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Lupus anticoagulant; Obstetric outcome

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CESAREAN SECTION; COMPLICATION; DEEP VEIN THROMBOSIS; EPIDEMIOLOGY; FEMALE; FETUS OUTCOME; HUMAN; INTRAUTERINE GROWTH RETARDATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; PRIORITY JOURNAL; RECURRENT ABORTION; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

EID: 0030852373     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600606     Document Type: Article

References (23)

1. Lubbe WF, Palmer SJ, Butler WS, Liggins GC. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983; 1: 1361-1365.
2. Cowchock FS et al. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomised trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166(5): 1318-1323.
3. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987; 26: 324-326.
4. Lockwood CT et al. The prevalence and biological significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369-373.
5. MacLean MA et al. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriage. Br J Obstet Gynecol 1994; 101: 103-106.
6. Unander AM, Norberg R, Hahn L, Arfos L. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am J Obstet Gynecol 1991; 156: 114-119.
7. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arth Rheum 1991; 34: 1231-1235.
8. Khong TY, de Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. Br J Obstet Gynecol 1986; 93: 1049-1059.
9. Branch WD et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/C mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163: 210-216.
10. Quenby S, Farquharson R. Predicting recurring miscarriage - what is important? Obstet Gynecol 1993; 82: 132-138.
11. Thiagarajan P, Pengo V, Shapiro SS. The use of dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-874.
12. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4th April, 1986. Clin Exp Immunol 1987; 68: 215-222.
13. Davey DA, MacGillivary HI. The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-898.
14. Clifford KA, Regan L. Recurrent pregnancy loss. Prog Obstet Gynaecol 1993; 11: 97.
15. Out HJ, Kooijman CD, Bruinse HW, Derksen RHWM. Histopathological findings in placentae from patients with intra-uterine fetal death and antiphospholipid antibodies. Eur J Obstet Gynaecol Reprod Biol 1991; 341: 179-186.
16. Ware Branch D. Antiphospholipid syndrome; laboratory concerns, fetal loss, and pregnancy management. Sem Perinatol 1991; 15(3): 230-237.
17. Dahlman T, Sjoberg HE, Ringertz H. Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynecol 1994; 170: 1315-1320.
18. Sheftas J, Farquharson RG. Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol 1996; 65: 171-174.
19. Black A et al. Assessment of biochemical markers of bone turnover in pregnant women. Current Research in Osteoporosis and Bone Mineral Management National Osteoporosis Conference 1996, p 21 (Abstract).
20. Kutteh WH. Antiphosphohpid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584-1589.
21. Rai RS, Regan L, Dave M, Cohen H. Randomised trial of aspirin versus aspirin and heparin in pregnant women with the antiphospholipid syndrome. Lupus 1996; 5(5): 518 (Abstract).
22. Ginsberg IS et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685-3691.
23. Branch DW et al. The association of antiphospholipid antibodies with severe pre-eclampsia. Obstet Gynecol 1989; 73: 541-545.